CI Investments Inc’s MacroGenics MGNX Stock Holding History

CI Investments Inc’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-31,681	Closed	-$279K	–	1348
2022 Q1	$279K	Buy	+31,681	New	+$350K	﹤0.01%	646

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

CI Investments Inc's MGNX Position: Q2 2022 in Review

CI Investments Inc sold out of MacroGenics (MGNX) in Q2 2022, closing a stake of 31,681 shares — an estimated $279K sold.

CI Investments Inc first reported a position in MGNX in Q1 2022 and held it in 1 quarter. The position peaked at $279K in Q1 2022. 133 funds tracked by Wall St. Rank hold MGNX as of Q2 2022.

CI Investments Inc reported no remaining MacroGenics position as of Q2 2022 after selling out during the quarter.
CI Investments Inc sold 31,681 MacroGenics shares in Q2 2022, an estimated $279K.
CI Investments Inc first reported a position in MacroGenics in Q1 2022 and held it in 1 quarter.
CI Investments Inc's MacroGenics position peaked at $279K in Q1 2022.
133 funds tracked by Wall St. Rank held MacroGenics as of Q2 2022.

Based on CI Investments Inc's 13F filing for Q2 2022, filed 12 Aug 2022.